Thrombophilia Screening: Not So Straightforward

被引:4
|
作者
Moore, Gary W. [1 ,2 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Haemophilia & Thrombophilia Ctr, Specialist Haemostasis Lab, Cambridge, England
[2] Middlesex Univ, Dept Nat Sci, London, England
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2024年 / 50卷 / 08期
关键词
activated protein C resistance; antithrombin; protein C; protein S; thrombophilia; PROTEIN-S DEFICIENCY; FACTOR-V-LEIDEN; DEEP-VEIN THROMBOSIS; PLASMA COAGULATION INHIBITORS; INDUCED SKIN NECROSIS; GENETIC RISK-FACTOR; C RESISTANCE; DEVELOPMENTAL HEMOSTASIS; PROTHROMBIN MUTATION; C4B-BINDING PROTEIN;
D O I
10.1055/s-0044-1786807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although inherited thrombophilias are lifelong risk factors for a first thrombotic episode, progression to thrombosis is multifactorial and not all individuals with inherited thrombophilia develop thrombosis in their lifetimes. Consequently, indiscriminate screening in patients with idiopathic thrombosis is not recommended, since presence of a thrombophilia does not necessarily predict recurrence or influence management, and testing should be selective. It follows that a decision to undertake laboratory detection of thrombophilia should be aligned with a concerted effort to identify any significant abnormalities, because it will inform patient management. Deficiencies of antithrombin and protein C are rare and usually determined using phenotypic assays assessing biological activities, whereas protein S deficiency (also rare) is commonly detected with antigenic assays for the free form of protein S since available activity assays are considered to lack specificity. In each case, no single phenotypic assay is capable of detecting every deficiency, because the various mutations express different molecular characteristics, rendering thrombophilia screening repertoires employing one assay per potential deficiency, of limited effectiveness. Activated protein C resistance (APCR) is more common than discrete deficiencies of antithrombin, protein C, and protein S and also often detected initially with phenotypic assays; however, some centres perform only genetic analysis for factor V Leiden, as this is responsible for most cases of hereditary APCR, accepting that acquired APCR and rare F5 mutations conferring APCR will go undetected if only factor V Leiden is evaluated. All phenotypic assays have interferences and limitations, which must be factored into decisions about if, and when, to test, and be given consideration in the laboratory during assay performance and interpretation. This review looks in detail at performance and limitations of routine phenotypic thrombophilia assays.
引用
收藏
页码:1131 / 1152
页数:22
相关论文
共 50 条
  • [21] Screening for thrombophilia: a laboratory perspective
    Jennings, I
    Cooper, P
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2003, 60 (01) : 39 - 51
  • [22] A mnemonic for thrombophilia screening tests
    Hall, TN
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 168 (06) : 312 - 312
  • [23] POSITIVE HIV VIRAL LOAD: NOT SO STRAIGHTFORWARD
    Dinh, Son Quyen H.
    Dubow, Joshua
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S631 - S631
  • [24] Cryptocurrencies market efficiency ranking: Not so straightforward
    Kristoufek, Ladislav
    Vosvrda, Miloslav
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2019, 531
  • [25] Income inequality and financialization: a not so straightforward relationship
    Alexiou, Constantinos
    Trachanas, Emmanouil
    Vogiazas, Sofoklis
    JOURNAL OF ECONOMIC STUDIES, 2022, 49 (01) : 95 - 111
  • [26] Laboratory thrombophilia screening: essentials for hematologists
    Kyrle, Paul A.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (04) : 360 - 363
  • [27] Is screening for thrombophilia cost-effective?
    Wu, Olivia
    Greer, Ian A.
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 500 - 503
  • [28] THROMBOPHILIA SCREENING IN LIVING LIVER DONORS
    Dayangac, Murat
    Akyildiz, Murat
    Kucukkaya, Reyhan
    Guler, Necdet
    Oklu, Levent
    Yuzer, Fisun
    Altaca, Gulum
    Yuzer, Yildiray
    Tokat, Yaman
    TRANSPLANT INTERNATIONAL, 2013, 26 : 156 - 156
  • [29] Thrombophilia screening in young ischaemic strokes
    Duncan, S.
    Simister, R.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 31 - 31
  • [30] Is a nihilistic attitude to thrombophilia screening justified?
    Hunt, BJ
    Shannon, M
    Bevan, D
    Murday, V
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (05) : 918 - 918